Physician profile
Albert Ruenes
NPI 1831193226
$5,347.51
in general payments reported to CMS, 2019-2025
43 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $350 · 2021: $1,051 · 2022: $1,178 · 2023: $1,130 · 2024: $940 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,404.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,488.17 | 2021-2025 | Interstim, Biosyn |
| Astellas Pharma US INC | $618.09 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $601.85 | 2019-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $282.19 | 2019-2023 | Spaceoar Vue System - 10ml, Solyx Sis System |
| Bayer Healthcare Pharmaceuticals INC. | $168.49 | 2022-2023 | |
| Blue Earth Diagnostics | $162.62 | 2023-2025 | Posluma |
| Coloplast Corp | $153.37 | 2019-2025 | Speedicath |
| Olympus America INC. | $139.25 | 2021-2025 | Itind System |
| Medtronic USA, INC. | $131.85 | 2020 | |
| Sumitomo Pharma America, INC. | $125.63 | 2023-2025 | Orgovyx, Gemtesa |
| Photocure INC | $105.85 | 2019-2024 | Cysview |
| Teleflex LLC | $92.07 | 2023-2024 | Urolift |
| Telix Pharmaceuticals | $87.92 | 2023 | Illuccix |
| Merck Sharp & Dohme LLC | $87.66 | 2022-2024 | Keytruda, Lynparza |
| Pfizer INC. | $86.02 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Ruenes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.